WHO ICTRP trial
Dexamphetamine effects on the perceptions of visual, auditory, tactile and…
ACTRN12615000619549 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615000619549 |
|---|---|
| Public title | Dexamphetamine effects on the perceptions of visual, auditory, tactile and multimodal illusions in healthy volunteers |
| Scientific title | Dexamphetamine effects on healthy volunteers in a cross-over design on the perceptions of visually, auditory, tactile and multimodal illusions |
| Primary sponsor | Mathew Martin-Iverson |
| Secondary sponsors | Dr Joseph Lee;Dr Rajan Iyyalol |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | This is a dexamphetamine challenge study in healthy volunteers as a model for studying dopaminergic mechanisms in psychoses; This is a dexamphetamine challenge study in healthy volunteers as a model for studying dopaminergic mechanisms in… |
| Interventions | dexamphetamine (0.45 mg/kg, by mouth with gelatine capsules) once only, and placebo: gelatine capsules filled with glucose. The two treatments are given about a week apart (minimum 5 days). Dexamphetamine levels determined from five saliva… |
| Registration date | Jun 15, 2015 |
| Target size | 72 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: